Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA-seq03:21

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular Effects of Droperidol: A Clinically-Focused Review for the Consultation-Liaison and Emergency Psychiatrist.

Journal of the Academy of Consultation-Liaison Psychiatry·2026
Same author

Religious and Spiritual Behaviors Correlated with Mental and Physical Well-Being Among American Muslims within the Twin Cities.

Journal of religion and health·2026
Same author

Evaluating methylphenidate as a potential treatment for cocaine use disorder: a propensity score-matched study.

The American journal of drug and alcohol abuse·2026
Same author

Evaluating the Impact of Blood-Brain Barrier-Penetrant ACE Inhibitors on HIV-Associated Neurocognitive Disorders.

Journal of acquired immune deficiency syndromes (1999)·2026
Same author

CDK8 and CDK19 Mediator kinases are required for hepatitis delta virus replication.

Hepatology (Baltimore, Md.)·2026
Same author

Host-derived interleukin-1α drives tumor immunosuppression by reprogramming tumor-associated myeloid cells.

NPJ breast cancer·2026
Same journal

Costunolide ameliorates autoimmune uveitis by targeting USP15 to suppress TNF-α-induced retinal endothelial inflammation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

A ligandable PNT domain establishes ERG as a directly targetable oncogenic driver in prostate cancer.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Identification of cellular intermediates unveils unique enzymes for flagellar glycan biosynthesis in <i>Clostridioides difficile</i>.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

The structure of correlated variability reflects task-relevant information in sensory neurons.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Shared neurogenetic substrates of nonplanning impulsivity and procrastination.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

HIV-1 capsid interactions with Nuclear Pore Complex components support nuclear entry via affinity gradient.

Proceedings of the National Academy of Sciences of the United States of America·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

Function-based gene identification using enzymatically generated normalized shRNA library and massive parallel

Michael Shtutman1, Anil Maliyekkel, Yu Shao

  • 1Cancer Center, Ordway Research Institute, Albany, NY 12208, USA.

Proceedings of the National Academy of Sciences of the United States of America
|April 7, 2010
PubMed
Summary
This summary is machine-generated.

This study developed a novel RNA interference (RNAi) library to identify genes that regulate cell growth. The library successfully identified potential cancer drug targets by screening for genes inhibiting breast carcinoma cell growth.

More Related Videos

Retrospective MicroRNA Sequencing: Complementary DNA Library Preparation Protocol Using Formalin-fixed Paraffin-embedded RNA Specimens
12:24

Retrospective MicroRNA Sequencing: Complementary DNA Library Preparation Protocol Using Formalin-fixed Paraffin-embedded RNA Specimens

Published on: May 5, 2018

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Related Experiment Videos

Last Updated: Jun 14, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

Retrospective MicroRNA Sequencing: Complementary DNA Library Preparation Protocol Using Formalin-fixed Paraffin-embedded RNA Specimens
12:24

Retrospective MicroRNA Sequencing: Complementary DNA Library Preparation Protocol Using Formalin-fixed Paraffin-embedded RNA Specimens

Published on: May 5, 2018

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Developing effective strategies for function-based gene identification is crucial for understanding cellular processes and disease mechanisms.
  • RNA interference (RNAi) offers a powerful tool for gene silencing, but optimizing short hairpin RNA (shRNA) efficacy remains a challenge.
  • Identifying novel cancer targets requires efficient high-throughput screening methods.

Purpose of the Study:

  • To create and validate a comprehensive shRNA library for function-based gene identification.
  • To establish structural criteria for enhancing shRNA efficacy.
  • To identify novel cancer drug targets by screening for genes that inhibit breast carcinoma cell growth.

Main Methods:

  • Enzymatic generation of a normalized human cDNA-derived shRNA library in an inducible lentiviral vector.
  • Measurement of RNAi activities for 101 shRNA clones targeting 100 human genes and 201 shRNAs targeting firefly luciferase.
  • Structure-activity analysis to derive criteria for shRNA efficacy.
  • Selection of shRNAs inhibiting breast carcinoma cell growth to identify potential oncogenes and cancer targets.

Main Results:

  • Structure-activity analysis identified criteria that increased active shRNA frequencies up to 5-fold.
  • Screening identified 119 potential cancer drug targets, enriched in cancer-associated pathways.
  • Short interfering RNAs (siRNAs) targeting 19 of 22 validated genes inhibited cell growth, confirming target identification efficiency.

Conclusions:

  • The developed shRNA library and structure-activity analysis provide an efficient strategy for high-throughput target gene identification.
  • This approach successfully identified novel genes and pathways implicated in cancer, offering promising avenues for drug development.
  • The validated strategy demonstrates significant potential for accelerating the discovery of new cancer therapies.